Substitute bony matrix products promoting osteogenesis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5071436
SERIAL NO

07701607

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A new composition is disclosed which serves as a substitute for the bony matrix material present in bones. The new composition includes an association of collagen-hydroxy-apatite and a glycosaminoglycan. The concentration of the hydroxyapatite is preferably 15 to 25% and the concentration of the glycosaminoglycan is between 1 and 2% per liter of 1% collagen gel. The biomaterial product is useful in applications in reconstructive orthopedic surgery as a substitute for natural bone matrix material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BASF BEAUTY CARE SOLUTIONS FRANCE SAS69007 LYON

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allard, Roland Saint Chamond, FR 4 160
Bejui, Jacques Lyons, FR 3 122
Huc, Alain Sainte-Foy-Les-Lyon, FR 28 930

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation